Skip to main content

# Jeffrey Crawford

George Barth Geller Distinguished Professor for Research in Cancer
Medicine, Medical Oncology
jeffrey.a.crawford@duke.edu
Duke Box 3476, Durham, NC 27710
25177 Morris Bldg, Durham, NC 27710
Manage Profile
Embed Profile Data

## Overview

1. Lung cancer/new treatment approaches.
2. Clinical trials of hematopoietic growth factors, biological agents and targeted drug development.
3. Cancer in the elderly and supportive care
Accomplishments
1. Lead Investigator of the U. S. multicenter, randomized trial of Filgrastim (G-CSF, Neupogen) to reduce the morbidity of chemotherapy-related neutropenia, leading to FDA approval 2/91.
2. Lead Investigator of the U. S. multicenter, randomized trial of Vinorelbine (Navelbine) in treatment of patients with advanced non small cell carcinoma of lung (NSCLC), leading to FDA approval 12/94.
3. Principal Investigator in initial phase I clinical trials of stem cell factor (SCF), megakaryocyte growth and development factor (MGDF), pegylated granulocyte-colony-stimulating factor and other novel hematopoietic growth factors.

## Current Appointments & Affiliations

George Barth Geller Distinguished Professor for Research in Cancer · 2005 - Present Medicine, Medical Oncology, Medicine
Professor of Medicine · 1997 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 1974 - Present Duke Cancer Institute, Institutes and Centers

## Education, Training & Certifications

Ohio State University · 1974 M.D.